DISAB

Connect with us

National

SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question – The Lancet

Since the onset of the COVID-19 pandemic, SARS-CoV-2 vaccine development has progressedat an unprecedented rate, with recent phase 3 trial data offering the tantalising…

Published

on